Home » Topics » Regulatory

Regulatory
RSS

FDA approves three alogliptin-based therapies for type 2 diabetes

Jan. 28, 2013

Novartis receives E.U. approval for Bexsero

Jan. 23, 2013

FDA approves first patch for treatment of migraine

Jan. 18, 2013

FDA approves Protein Sciences' Flublok seasonal influenza vaccine

Jan. 17, 2013

Biocon receives marketing authorization in India for itolizumab

Jan. 10, 2013

FDA approves Kineret for the treatment of NOMID

Jan. 10, 2013

FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS

Jan. 2, 2013

FDA grants accelerated approval for Sirturo in tuberculosis

Jan. 2, 2013

FDA approves Juxtapid for homozygous familial hypercholesterolemia

Dec. 27, 2012

FDA expands approval of Tamiflu

Dec. 24, 2012